bims-imicid Biomed News
on Immunometabolism of infection, cancer and immune-mediated disease
Issue of 2026–11–22
forty-six papers selected by
Dylan Gerard Ryan, Trinity College Dublin



  1. J Inflamm (Lond). 2026 Aug 24. pii: 28. [Epub ahead of print]23(1):
       BACKGROUND: Mitochondria serve as central regulators of cellular bioenergetics and inflammatory signaling, integrating metabolic status with immune responses. Disruption of mitochondrial homeostasis, including altered tricarboxylic acid cycle dynamics, redox imbalance, and aberrant reactive oxygen species production, contributes to persistent inflammation and disease pathogenesis. Among emerging mitochondrial immunometabolic regulators, the IRG1/ACOD1-derived metabolite itaconate has gained attention as a critical molecular integrator linking mitochondrial metabolism to inflammatory control.
    MAIN BODY: This review systematically summarizes the biosynthesis of itaconate and its role in mitochondrial metabolic remodeling during inflammation. Itaconate reshapes the tricarboxylic acid cycle and inhibits succinate dehydrogenase, thereby limiting mitochondrial reactive oxygen species generation and preventing amplification of pro-inflammatory signaling. Through covalent modification of KEAP1, it activates the NRF2 antioxidant program, while concurrently restraining NLRP3 inflammasome activation, establishing a mitochondrial metabolic checkpoint that constrains excessive immune activation. Beyond acute metabolic regulation, itaconate coordinates sustained immunoregulatory programs via the ATF3-IκBζ transcriptional axis, autophagy-lysosome system modulation, and epigenetic reprogramming. We further integrate cell-type-specific effects of itaconate across macrophages, dendritic cells, T cells, and neutrophils, and discuss how mitochondrial immunometabolic dysregulation contributes to chronic inflammatory and metabolic disorders.
    CONCLUSION: By positioning the IRG1-itaconate axis within the broader framework of mitochondrial immunometabolism, this review highlights mitochondria as a central hub linking metabolic remodeling with inflammatory regulation. Targeting mitochondrial metabolic checkpoints such as the itaconate pathway may provide promising therapeutic strategies for restoring immune homeostasis and treating inflammation-associated diseases.
    DOI:  https://doi.org/10.1186/s12950-026-00510-z
  2. Inflammation. 2026 Aug 18. pii: 225. [Epub ahead of print]49(1):
      Atherosclerosis and myocardial infarction remain the predominant contributors to mortality despite advances in interventional cardiology. Chronic inflammatory responses mediated by macrophages serve as a critical determinant of the pathogenesis of cardiovascular diseases. This review systematically dissects the immunometabolic and signaling networks underlying macrophage reprogramming, with a focus on key cardiovascular diseases. We assess the characteristics of M1 macrophages, which involve aerobic glycolysis, activation of the pentose phosphate pathway, and disruption of the tricarboxylic acid cycle, compared to M2 macrophages that rely on oxidative phosphorylation and fatty acid oxidation. Integrated signaling pathways dynamically regulate these metabolic programmes-centred on TLR/NF-κB-mediated inflammatory priming, JAK/STAT-dependent transcriptional polarization, and PI3K/Akt/mTOR-AMPK-PPARγ metabolic checkpoints, which interpret microenvironmental signals to control macrophage polarization. Within atherosclerotic lesions, we demonstrate that M1-dominant macrophage populations exacerbate plaque inflammation and compromise structural integrity, whereas M2 macrophages augment inflammatory resolution and tissue restoration. Following myocardial infarction, the timely therapeutic reprogramming from M1 to M2 phenotype is essential for efficiently attenuating adverse cardiac remodeling and improving cardiac function. Targeting metabolic enzymes and signaling pathways offers a promising strategy for reprogramming macrophages and mitigating cardiovascular diseases.
    Keywords:  Atherosclerosis; Immunometabolism; Macrophage polarization; Myocardial infarction; Signaling pathways
    DOI:  https://doi.org/10.1007/s10753-026-02542-2
  3. bioRxiv. 2026 Nov 13. pii: 2026.03.23.713618. [Epub ahead of print]
      Drosophila larval hemocytes, analogous to vertebrate myeloid cells, are central to innate immunity. Despite advances in characterizing hemocyte functions via genetic and biochemical analyses, their metabolic characteristics remain poorly understood. Here, we analyzed metabolic parameters of larval hemocytes across developmental stages, genotypes, and immune activation states using metabolic measurements and single-cell transcriptomics. Our results reveal that hemocytes predominantly rely on mitochondrial respiration for ATP production under homeostasis, with minimal glycolysis. Proliferation or immune activation, particularly lamellocyte differentiation, enhance mitochondrial activity and metabolic flexibility, accompanied by mitochondrial structural remodeling and upregulation of sugar metabolism genes. Functional lamellocytes modulate mitochondrial fission through Drp1 and utilize glucose and trehalose to fuel mitochondrial respiration, which are essential for effective immune responses. Together, these findings provide a comprehensive profile of hemocyte metabolism and highlight the dynamic interplay between mitochondrial metabolism and innate immunity in invertebrate immune cells.
    DOI:  https://doi.org/10.64898/2026.03.23.713618
  4. J Inflamm Res. 2026 ;19 639333
      Rheumatoid arthritis (RA) is a systemic autoimmune disease in which inflammatory signaling and cellular metabolism interact within the synovial microenvironment. This narrative review critically examines glucose, lipid and amino-acid metabolism, mitochondrial dysfunction, and their cell-specific roles in synovial fibroblasts, macrophages, lymphocytes and other joint-resident or infiltrating cells. Human tissue and observational metabolomic studies support the presence of metabolic alterations in RA, whereas causal mechanisms are established predominantly through experimental perturbation in cell-based and animal models. Lactate, lipid signatures, kynurenine-pathway metabolites and oxidative-stress measures are promising candidate biomarkers, but none of the metabolic endotypes discussed here is established as a clinically validated tool for treatment selection. Methotrexate and approved disease-modifying antirheumatic drugs remain the clinical standard; direct glycolytic or glutaminolytic inhibitors, repurposed metabolic modulators, traditional Chinese medicine interventions, stimulus-responsive carriers, and nucleic-acid or gene-based approaches require substantially more RA-specific clinical validation. We synthesize the evidence by model and translational maturity, highlight conflicting or context-dependent observations, and identify key barriers including cohort heterogeneity, assay standardization, off-target toxicity and prospective validation. The resulting framework positions immunometabolism as a testable contribution to RA biology rather than an established precision-treatment algorithm.
    Keywords:  candidate biomarkers; evidence appraisal; immunometabolism; metabolic reprogramming; rheumatoid arthritis; translational medicine
    DOI:  https://doi.org/10.2147/JIR.S639333
  5. Mol Med. 2026 Oct 30. pii: 224. [Epub ahead of print]32(1):
       BACKGROUND: Rheumatoid arthritis (RA) is sustained by reciprocal interactions among immune, stromal, vascular and tissue-remodeling cells within a hypoxic, oxidant-rich and nutrient-competitive synovial environment. Extracellular vesicles (EVs) can transfer RNAs, proteins, lipids and other bioactive cargo between these compartments, but the RA-EV literature often invokes immunometabolic reprogramming without directly measuring metabolism.
    MAIN BODY: We examine evidence linking EVs, immunometabolism and RA and distinguish direct metabolic effects from metabolism-linked mechanisms, context-dependent immune phenotypes and patient-derived biomarker observations. Among the endogenous studies examined, M1-macrophage EV-associated miR-155 provides a clear example in which recipient CD4 + T-cell metabolic function was measured, including extracellular acidification, oxygen consumption, lactate excretion and intracellular ATP levels. Most other endogenous studies identify metabolism-related cargo, signaling pathways or immune phenotypes without directly establishing recipient-cell metabolic reprogramming. An engineered plant vesicle formulation loaded with spermidine also altered macrophage extracellular acidification and oxygen consumption in experimental models. These findings should be distinguished from patient-derived EV associations and from engineered systems in which an exogenous drug or catalytic material may account for the principal effect.
    CONCLUSION: Direct measurements of recipient-cell metabolism remain uncommon in RA-EV research. Stronger studies will require well-described EV preparations, EV- and cargo-dependence controls, functional metabolic assays, physiologically plausible dosing and validation in primary human RA systems. In the future, these approaches could inform mechanism-based patient stratification, externally validated biomarkers and targeted EV-based delivery. These are research opportunities: patient-derived EV findings have not yet established a clinically useful test, and EV-based therapy has not established clinical efficacy in RA.
    Keywords:  Biomarkers; EV therapeutics; Extracellular vesicles; Fibroblast-like synoviocytes; Glycolysis; Immunometabolism; Lipid mediators; Macrophages; Redox homeostasis; Rheumatoid arthritis
    DOI:  https://doi.org/10.1186/s10020-026-01684-1
  6. Autoimmunity. 2026 Dec 31. 59(1): 2763849
      Sepsis-associated acute respiratory distress syndrome (sepsis-ARDS) remains a life-threatening critical illness with limited targeted therapeutics, where pulmonary macrophage M1 polarization and aerobic glycolysis act as core drivers of inflammatory lung injury. Anterior gradient 3 (AGR3), an endoplasmic reticulum disulfide isomerase, was recently identified as a dysregulated transcript in human ARDS patient datasets, yet its immunometabolic function in septic lung injury remains undefined. Here, we aimed to characterize the role and molecular cascade of AGR3 in regulating macrophage polarization and glycolytic reprogramming during polymicrobial sepsis, combining the in vivo CLP septic mouse model with an in vitro LPS/IFN-γ-induced M1 polarization model in RAW264.7 macrophages. Bioinformatic mining of GSE66890 RNA-seq dataset revealed prominent AGR3 upregulation in human ARDS lung tissues, which we validated in cecal ligation and puncture (CLP)-induced septic mouse lungs and LPS/IFN-γ-stimulated RAW264.7 macrophages. Lentiviral-mediated AGR3 knockdown suppressed M1 macrophage polarization, reduced glycolytic flux (lower ECAR, higher OCR, diminished lactate secretion), and blunted pro-inflammatory cytokine release in vitro. Mechanistic biochemistry assays demonstrated that AGR3 physically interacts with hypoxia-inducible factor 1α (HIF-1α), extending HIF-1α protein half-life by restraining proteasomal degradation and promoting its nuclear translocation. Chromatin immunoprecipitation confirmed that stabilized nuclear HIF-1α transcriptionally activates pyruvate kinase M2 (Pkm2), a master glycolytic effector. Reciprocal rescue experiments verified that ectopic overexpression of HIF-1α or PKM2 largely reversed the anti-inflammatory, metabolic phenotypes induced by AGR3 silencing. In vivo intratracheal AAV9-shAGR3 delivery mitigated CLP-triggered pulmonary edema, neutrophil infiltration, M1 macrophage accumulation, and restored protective PKM2 tetramer formation, accompanied by significant improvement in pulmonary function and 7-day survival of septic mice. Taken together, AGR3 mediates sepsis-induced lung injury via the HIF-1α/PKM2 signaling. This study provides a novel potential therapeutic target for sepsis-associated ARDS.
    Keywords:  AGR3; HIF-1α; PKM2; Sepsis; macrophage polarization
    DOI:  https://doi.org/10.1080/08916934.2026.2763849
  7. Cell Rep. 2026 Nov 17. pii: S2211-1247(26)01401-4. [Epub ahead of print]45(11): 118322
      Sepsis is characterized by persistent immune dysfunction but how metabolic alterations contribute to immunosuppression remains unclear. Here, we identify lactate as a regulator of regulatory T cell (Treg) differentiation and show that Treg accumulation contributes to persistent organ injury during sepsis. In patients with sepsis, plasma lactate correlates with circulating Treg frequencies and disease severity. Lactate uptake through MCT1 increases H3K9 and H3K18 lactylation and Prmt5 transcription. Lactate also increases S-adenosylmethionine, supporting PRMT5-mediated symmetric dimethylation of Foxp3 at R51 and R146, which stabilizes Foxp3 and promotes Treg differentiation and suppressive function. CD4+ T cell-specific Prmt5 deletion attenuates lactate-induced Treg responses and improves outcomes in septic mice. Dexmedetomidine binds the PRMT5/MEP50 complex, reduces Treg accumulation and organ injury, and improves host defense against secondary infection. These findings link lactate metabolism to PRMT5-dependent Foxp3 stabilization and suggest a potential therapeutic pathway for sepsis-associated immunosuppression.
    Keywords:  CP: immunology; Foxp3; PRMT5; dexmedetomidine; histone lactylation; immunosuppression; lactate; regulatory T cell; sepsis; symmetric dimethylation
    DOI:  https://doi.org/10.1016/j.celrep.2026.118322
  8. Front Med (Lausanne). 2026 ;13 1967105
      Gout is a metabolic inflammatory disease whose pathogenesis involves the complex interaction between metabolic reprogramming and immune homeostasis imbalance. This review focuses on the bidirectional network through which the HIF-1α/HK2 axis regulates the Th17/Treg balance via glycolytic reprogramming. Monosodium urate (MSU) crystals drive enhanced aerobic glycolysis in macrophages through the GLUT1-JNK-HIF-1α signaling axis, where hexokinase 2 (HK2), as a metabolic checkpoint, connects glycolysis with NLRP3 inflammasome activation and neutrophil extracellular trap (NETosis)-induced M1 polarization. The glycolytic metabolic bias promotes the differentiation of T helper 17 (Th17) cells while inhibiting the generation of regulatory T (Treg) cells. In turn, cytokines derived from Th17/Treg cells reversely regulate the metabolic status of antigen-presenting cells, forming a feedback loop for inflammation amplification or resolution. Based on this network model, intervention strategies targeting the HIF-1α/HK2/mTOR glycolytic axis and metabolic checkpoints (such as HK2, PKM2), including chaetocin, rapamycin, and various natural products, have shown therapeutic potential for restoring immune homeostasis. Current evidence mainly comes from animal models and in vitro experiments. In the future, it is necessary to use single-cell multi-omics technology to resolve the heterogeneity of the immunometabolic landscape, and to verify the dynamic regulatory mechanism of this network in the self-limiting resolution of gout inflammation.
    Keywords:  HIF-1α; HK2; NLRP3 inflammasome; Th17/Treg balance; glycolysis; gout; metabolic reprogramming
    DOI:  https://doi.org/10.3389/fmed.2026.1967105
  9. Eur J Pharmacol. 2026 Nov 18. pii: S0014-2999(26)01069-1. [Epub ahead of print]1040 179587
      Accumulating evidence underscores that PDE4B expression is significantly upregulated in patients with inflammatory bowel disease (IBD). However, its therapeutic potential and the underlying molecular mechanisms in pediatric IBD remain poorly defined. In this study, multiple public datasets were analyzed to characterize PDE4B expression in pediatric IBD. This was followed by therapeutic evaluation in mice colitis models to validate the efficacy of PDE4B inhibition in vivo. Analysis of public datasets revealed a marked elevation of PDE4B in pediatric IBD cohorts. Mechanistically, we demonstrated that a PDE4B inhibitor effectively suppressed LPS-induced inflammatory responses in primary blood samples from pediatric patients. In murine models, pharmacological inhibition of PDE4B significantly attenuated intestinal inflammation in both DSS- and LPS-induced colitis models. Furthermore, treatment with the PDE4B inhibitor successfully alleviated established chronic mucosal injury and preserved goblet cell integrity in spontaneous Il10-/- mice. Furthermore, 16S rRNA gene sequencing demonstrated that PDE4B inhibition was associated with a partial restoration of gut microbiota diversity and a reduction in specific bacterial dysbiosis. At the molecular level, the inhibitor promoted the activation of the anti-inflammatory mediator p-CREB while concurrently abrogating pro-inflammatory p-STAT3 signaling. Notably, the suppression of pathological glycolysis by the inhibitor was closely accompanied by the metabolic reprogramming and enhanced anti-inflammatory function. In conclusion, these findings suggest that targeting PDE4B represents a potential therapeutic approach for pediatric IBD by modulating macrophage immunometabolism and restoring intestinal homeostasis.
    Keywords:  Glycolysis; Inflammatory bowel disease; Macrophages; Metabolic reprogramming; Phosphodiesterase‐4B
    DOI:  https://doi.org/10.1016/j.ejphar.2026.179587
  10. J Transl Autoimmun. 2026 Dec;13 100414
       Background: Rheumatoid arthritis (RA) is a chronic inflammatory disease associated with metabolic reprogramming of immune cells. Although inflammatory cytokines have been extensively studied, the effects of disease-modifying therapies including methotrexate, infliximab and their combination on serum immunometabolic biomarkers remain incompletely understood.
    Methods: This cross-sectional study included newly diagnosed RA patients, patients receiving MTX monotherapy, patients receiving MTX plus infliximab, and healthy controls. Serum levels of tumor necrosis factor-alpha (TNF-α), interleukin-10 (IL-10), lactate, citrate, and succinate dehydrogenase (SDH) activity were measured. Disease activity was evaluated using the Disease Activity Score in 28 joints (DAS28). Statistical analyses, hierarchical clustering, correlation and network analyses, principal component analysis (PCA), and exploratory structural equation modeling (SEM) were used to investigate immunometabolic relationships and treatment-associated changes.
    Results: Newly diagnosed RA patients showed significantly elevated TNF-α, IL-10, lactate, SDH activity, TNF-α/IL-10 ratio, and DAS28, alongside reduced citrate levels compared with controls and treated patients. Combined MTX and infliximab therapy demonstrated the greatest improvement in inflammatory and metabolic biomarkers and the lowest disease activity. Multivariate analyses identified TNF-α, lactate, and DAS28 as major contributors to disease-associated variation, while citrate displayed an opposing metabolic pattern. Correlation and network analyses identified TNF-α as a central link between inflammation, metabolic remodeling, and disease severity. SEM suggested that treatment-associated reductions in TNF-α were related to decreased glycolytic activity, improved mitochondrial metabolism, and reduced disease activity.
    Conclusion: RA involves coordinated inflammatory and metabolic dysregulation. Combined MTX and infliximab therapy appears more effective than MTX alone in restoring immunometabolic balance.
    Keywords:  Immunometabolism; Inflammation; Infliximab; Methotrexate; Rheumatoid arthritis
    DOI:  https://doi.org/10.1016/j.jtauto.2026.100414
  11. J Virol. 2026 Nov 18. e0111326
      Hepatitis C virus (HCV) depends on host lipid metabolism and lipid droplets (LDs) for genome replication, assembly, and particle production, yet how LD structure and lipid utilization change over the course of infection remains incompletely understood. Here, we investigated the temporal remodeling of LD-associated metabolic pathways during HCV JFH-1 infection of human hepatoma Huh7 cells. HCV infection transiently increased LD fluorescence intensity at 24 h post-infection (hpi), followed by normalization or relative loss of LD signal at later time points. Concomitantly, LDs became progressively clustered and enlarged during late infection, despite reduced protein levels of the canonical LD fusion proteins CIDEA, CIDEB, and CIDEC, suggesting that HCV-induced LD enlargement is not associated with increased expression of CIDE proteins. Transcriptomic, RT-qPCR, and immunoblot analyses revealed time-dependent regulation of genes and proteins involved in LD structure, triglyceride synthesis, lipolysis, lipid uptake, and mitochondrial fatty acid utilization. Subcellular fractionation demonstrated preferential accumulation of fatty acids in mitochondrial fractions at 24-72 hpi. This redistribution was accompanied by increased oxygen consumption rate, elevated extracellular acidification, and progressive reactive oxygen species accumulation, indicating infection-associated metabolic activation and oxidative stress. Pharmacological inhibition of DGAT1-dependent LD biogenesis, LIPA-dependent lysosomal lipid hydrolysis, LIPE/HSL-dependent lipolysis, or CPT1-dependent mitochondrial fatty acid transport markedly reduced mitochondrial fatty acid accumulation and suppressed HCV-induced respiratory activity. Inhibition of LIPA or LIPE/HSL reduced both HCV RNA and core protein levels, whereas inhibition of CPT1 or DGAT1 had more pronounced effects on core protein than on viral RNA. Together, these findings support a model in which HCV dynamically remodels LDs, mobilizes LD-associated fatty acids, and redirects them toward mitochondria to support infection-associated metabolism and downstream stages of the viral life cycle. Lipid hydrolysis and mitochondrial fatty acid trafficking therefore represent potential host-directed targets for limiting HCV infection.IMPORTANCEHepatitis C virus depends on host lipid metabolism for replication, assembly, and production of infectious particles, but how it uses lipid droplets over time remains incompletely understood. This study shows that hepatitis C virus dynamically remodels lipid droplets, causing an early increase in lipid storage followed by droplet enlargement and mobilization of fatty acids during later infection. The released fatty acids preferentially accumulate in mitochondria, where they are associated with increased cellular respiration and oxidative stress. Blocking lipid droplet formation, lipid breakdown, or fatty acid transport to mitochondria reduced this metabolic response and decreased viral RNA or core protein accumulation. Inhibition of lysosomal acid lipase and hormone-sensitive lipase suppressed both viral RNA and protein levels. These findings identify lipid droplet breakdown and mitochondrial fatty acid trafficking as important host processes used by hepatitis C virus and as potential targets for host-directed antiviral intervention.
    Keywords:  beta-oxidation; fatty acid; hepatitis C virus; lipid droplet; lipid metabolism; mitochiondria
    DOI:  https://doi.org/10.1128/jvi.01113-26
  12. Mol Neurobiol. 2026 Nov 19. pii: 1050. [Epub ahead of print]63(1):
      Ischemic stroke triggers mitochondrial dysfunction and the subsequent release of mitochondrial DNA (mtDNA) into the cytosol, where it activates the cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) innate immune pathway and drives a complex neuroinflammatory response. This review synthesizes recent advances to examine how mitochondrial stress leads to mtDNA leakage across different brain cell types, how cGAS-STING signaling is activated in a cell-type-specific manner, and how this pathway interacts with immune cell metabolism to shape neurological outcomes. We propose that the net effect of cGAS-STING activation is not intrinsically protective or detrimental, but rather depends on the intensity and duration of the activating signal and on the metabolic state of the responding cell. A recurring theme from our analysis is that the consequences of pathway activation vary markedly among microglia, neurons, and astrocytes, and that this variation shifts over time as the inflammatory response evolves from the hyperacute to the chronic phase. On this basis, we evaluate three categories of therapeutic strategies, including preservation of mitochondrial integrity, direct inhibition of cGAS-STING components, and reprogramming of immune metabolism. We also discuss the barriers to clinical translation, such as limited blood-brain barrier penetration, the lack of cell-type-specific targeting, and the absence of validated biomarkers for patient selection. We conclude that effective therapy will require stage-specific and cell-selective strategies rather than uniform inhibition of the pathway, and that immunometabolic reprogramming may offer a more durable approach for promoting long-term recovery.
    Keywords:  CGAS-STING pathway; Immunometabolism; Ischemic stroke; Metabolic reprogramming; Microglia; Mitochondrial stress; MtDNA leakage; Neuroinflammation
    DOI:  https://doi.org/10.1007/s12035-026-06333-6
  13. iScience. 2026 Dec 22. 29(12): 118197
      Muscularis macrophages (MMs) are tissue-resident macrophages embedded in the gut muscle layer that regulate neuromuscular function. We show that aging causes metabolic remodeling of select small intestine (SI) MM subpopulations that share homeostatic features with microglia. These MMs, which are characterized by lipid droplet accumulation, show increased glycolytic and lipid-handling features, mitochondrial stress, increased lysosomal content, elevated inflammatory gene expression, and reduced phagocytic activity. Unlike SI, colon MMs are relatively resistant to this lipid-accumulating phenotype. Together, these findings show that MM metabolic aging in the gut is specific to region and subset and suggest that local intestinal environments and MM heterogeneity shape macrophage vulnerability during aging.
    Keywords:  aging; gastrointestinal motility; lipid metabolism; mitochondrial dysfunction; muscularis macrophages
    DOI:  https://doi.org/10.1016/j.isci.2026.118197
  14. Front Immunol. 2026 ;17 1973121
      Ulcerative colitis (UC) is fundamentally driven by epithelial barrier dysfunction and aberrant immune activation. Metabolic reprogramming, particularly the shift toward aerobic glycolysis, actively contributes to UC pathogenesis rather than merely resulting from inflammation. This review proposes the metabolic crossfire hypothesis-an integrative framework, supported by accumulating preclinical evidence but not yet definitively validated in humans-in which infiltrating immune cells (e.g. M1 macrophages, Th17 cells, and neutrophils) and intestinal epithelial cells (IECs) reciprocally fuel each other's pro-inflammatory and barrier-disrupting phenotypes through shared glycolytic pathways. First, this review outlines the core signaling hubs HIF-1α, NF-κB, and mTOR that have been implicated in driving immune cell glycolysis, and discusses their cell-type-specific manifestations. This review then examines the IEC switch from oxidative phosphorylation (OXPHOS) to aerobic glycolysis and its impact on barrier integrity. Central to this review is the bidirectional nature of this metabolic crossfire: immune cells may attack IECs via lactate, ROS, and cytokines, whereas damaged IECs may retaliate by releasing metabolites, chemokines, and damage-associated molecular patterns (DAMPs), potentially forming a self-amplifying loop. Finally, we translate these mechanistic insights into therapeutic implications, underscoring the necessity of cell-type-specific targeting, human-relevant models, and biomarker-guided translation to guide future clinical trials.
    Keywords:  glycolytic reprogramming; immune cells; intestinal epithelial cells; metabolic crosstalk; ulcerative colitis
    DOI:  https://doi.org/10.3389/fimmu.2026.1973121
  15. Bioact Mater. 2027 Apr;70 312-329
      Rheumatoid arthritis (RA) features chronic synovial inflammation and systemic immune disorders. Current treatments mainly rely on systemic immunosuppression, raising risks of infection and long-term immune injury. Local therapies reduce such risks but struggle to regulate systemic immunity. Emerging studies show the synovial immunometabolic microenvironment links local inflammation to systemic responses. Here, we developed a strategy based on chemically attenuated photosynthetic bacteria that couples lactate metabolism with photo-driven hydrogen production to achieve local metabolic reprogramming and systemic immune re-education. We screened a photosynthetic bacterial strain with high lactate metabolic capacity, which also exhibited enhanced hydrogen production. To ensure safety, bacteria were PEGylated to mask immunogenic moieties while preserving metabolic activity. Intra-articular injection disrupted pathological crosstalk and restored the Treg/Th17 balance locally. Circulating IL-6 levels decreased, restoring the systemic regulatory role of Tregs, thereby alleviating distant joint inflammation. These results demonstrate that local synovial metabolic reprogramming by engineered bacteria can induce systemic immune re-education, offering a conceptually new therapeutic strategy for treating autoimmune arthritis.
    Keywords:  Bioengineered microorganisms; Immune reprogramming; Lactate metabolism; Oxidative stress; Rheumatoid arthritis; Synovial microenvironment; Treg/Th17 balance
    DOI:  https://doi.org/10.1016/j.bioactmat.2026.11.004
  16. Cell Death Discov. 2026 Aug 24. pii: 463. [Epub ahead of print]12(1):
      Sepsis-induced acute lung injury (ALI) is a life-threatening syndrome characterized by overwhelming inflammation, immune dysregulation, and tissue damage. Metabolic reprogramming of macrophages has emerged as a central regulator of inflammatory responses. Extracellular vesicles (EVs) derived from mesenchymal stem cells (MSCs) offer therapeutic potential, but their molecular mechanisms in regulating immunometabolism during ALI remain unclear. Single-cell RNA sequencing (GSE207651) revealed enrichment of pro-inflammatory macrophages and activation of IL-1/TNF signaling in septic ALI. Human adipose-derived MSC-EVs (hADSC-EVs) were isolated and characterized by transmission electron microscopy, nanoparticle tracking analysis, and Western blotting. Their effects on macrophage metabolism and polarization were assessed using bulk RNA-seq, Real-Time Quantitative Polymerase Chain Reaction (RT-qPCR), Western blotting, flow cytometry, enzyme-linked immunosorbent assay (ELISA), and lipid staining. In vivo efficacy was validated in a cecal ligation and puncture (CLP)-induced murine ALI model, and the macrophage-dependency of this therapy was confirmed using a genetic LysM-Cre; iDTR macrophage-ablation model. hADSC-EVs delivered ABCF1 into macrophages, upregulating CPT1A and IL-10, which is associated with fatty acid oxidation pathways, and promoting M2 polarization while suppressing NF-κB/STAT1-mediated inflammatory signaling. Silencing CPT1A disrupted lipid metabolism-associated profiles, reduced M2 polarization, and amplified pro-inflammatory responses. In vivo, hADSC-EVs alleviated pulmonary injury, decreased IL-1β and TNF-α release, and reduced apoptosis and inflammatory infiltration in lung tissue. ABCF1-deficient EVs lost these protective effects, highlighting the central role of the ABCF1/CPT1A/IL-10 axis. Collectively, our findings identify the ABCF1/CPT1A/IL-10 axis as a key immunometabolic pathway through which hADSC-EVs modulate macrophage lipid profiles to suppress inflammation, reduce apoptosis, and protect against sepsis-induced ALI. These results provide novel mechanistic insights into the interplay between metabolism, immune regulation, and cell death, highlighting EV-based strategies as promising therapeutic interventions for septic lung injury. Graphical Abstract. hADSC-EVs Reprogram Lipid Metabolism via the ABCF1/CPT1A/IL-10 Axis, Promoting Macrophage M2 Polarization and Ameliorating Sepsis-Induced ALI.
    DOI:  https://doi.org/10.1038/s41420-026-03192-x
  17. Immunol Invest. 2026 Nov 16. 1-39
       BACKGROUND: Macrophages in the multiple myeloma (MM) microenvironment adopt diverse functional states that extend beyond the M1/M2 framework. This review examines how spatial niches and metabolic reprogramming shape macrophage function and contribute to therapy resistance.
    METHODS: We synthesized published mechanistic, single-cell, and spatial profiling studies, focusing on glycolytic, lipid, amino acid, and mitochondrial pathways across hypoxic, vascular, osteolytic, and extramedullary niches.
    RESULTS: The reviewed evidence suggests that tumor-derived signals, extracellular vesicles, and local metabolic conditions jointly shape macrophage states that can promote immune dysfunction, disease progression, and therapy resistance. Single-cell and spatial profiling studies link macrophage states to cellular neighborhoods, anatomical location, and metabolic context.
    CONCLUSIONS: Targeting macrophage signaling, metabolism, phagocytic checkpoints, and niche-specific pathways may help overcome therapy resistance in MM. Most supporting evidence comes from preclinical and in vitro studies, and these strategies require clinical validation.
    Keywords:  Immunometabolism; macrophages; multiple myeloma; spatial niches; therapy resistance
    DOI:  https://doi.org/10.1080/08820139.2026.2757126
  18. Eur J Pharmacol. 2026 Nov 16. pii: S0014-2999(26)01056-3. [Epub ahead of print]1040 179574
      Vitamin D3 (cholecalciferol) and its active metabolite calcitriol exert immunoregulatory effects, but their macrophage metabolic actions during intestinal inflammation remain incompletely defined. We examined oral vitamin D3 in experimental colitis and explored vitamin D receptor (VDR)-associated peroxisome proliferator-activated receptorγ (PPARγ) involvement in macrophage responses to calcitriol. In a dextran sulfate sodium-induced mouse model, oral vitamin D3 reduced disease activity, colonic injury, macrophage infiltration and inflammatory cytokine production, and partly normalized selected serum lipid parameters, with dose-related increases in serum 1,25-dihydroxyvitamin D3 (1,25-(OH)2D3). In lipopolysaccharide-stimulated bone marrow-derived macrophages, calcitriol lowered IL-6 and IL-12/23p40, increased IL-10 and TGF-β, reduced M1-like/M2-like macrophage ratio, and decreased intracellular triglyceride, cholesterol and lipid-droplet accumulation. Oral vitamin D3 restored colonic PPARγ expression, PPARγ knockdown attenuated the effects of calcitriol on cytokine release and lipid accumulation. Murine colon microarray data linked myeloid Pparg deficiency to higher expression of inflammatory genes and lower expression of selected lipid-metabolism genes. Human UC macrophages with detectable VDR transcripts had higher PPARγ-target and lipid-metabolism module scores. These findings support anti-colitic effects of oral vitamin D3 and suggest VDR-associated PPARγ involvement in the macrophage response to calcitriol.
    Keywords:  Calcitriol; Experimental colitis; Lipid droplets; Macrophage immunometabolism; PPARγ; Vitamin D receptor; Vitamin D(3)
    DOI:  https://doi.org/10.1016/j.ejphar.2026.179574
  19. Nat Commun. 2026 Oct 17. pii: 11733. [Epub ahead of print]17(1):
      Diabetic wound healing is profoundly impaired by macrophage metabolic dysfunction, which compromises angiogenesis. Here, we show a macrophage transketolase (TKT) as a crucial metabolic checkpoint governing vascular regeneration in diabetes. We demonstrate that loss of TKT in macrophages accelerates amino acid and fatty acid catabolism, elevates reactive oxygen species, and disrupts endothelial cell proliferation and differentiation. Mechanistically, hyperglycemia activates the AGEs-RAGE signaling cascade through suppressing TKT expression, establishing a pathological TKT-AGEs-RAGE axis that reprograms macrophage metabolism toward dysfunction. Then, we engineer a nanozyme-integrated hydrogel patch that selectively increases TKT level in macrophages, which rebalances macrophage metabolism, reduces oxidative stress, and rescues angiogenic capacity. In a diabetic pig model, localized delivery of the nano-system markedly accelerates wound closure and vascular repair. These findings not only elucidate a macrophage-specific TKT metabolic reprogramming mechanism for enhancing angiogenesis, but also offer a potential therapeutic strategy for the clinical management of diabetic wounds.
    DOI:  https://doi.org/10.1038/s41467-026-78765-6
  20. Front Immunol. 2026 ;17 1987314
      Exercise is increasingly recognized as a systemic modulator of immune and metabolic physiology, with potential relevance to immune aging, chronic low-grade inflammation, and host defense. This structured narrative review integrates evidence on the interplay among exercise, skeletal-muscle-derived signaling, mitochondrial adaptation, and nutritional context to develop a conceptual framework for immunometabolic reprogramming during immune aging. Literature was identified through searches of PubMed/MEDLINE, Web of Science, Scopus, and Google Scholar using combinations of terms related to exercise, myokines/exerkines, mitochondria, nutrition, immunosenescence, inflammaging, and host defense. We synthesize evidence across human, animal, and cellular studies, while distinguishing direct human findings from associative and preclinical mechanistic evidence. Particular attention is given to exercise-induced myokine signaling, mitochondrial biogenesis and function, metabolic flexibility, redox signaling, and mitochondrial quality control, as well as the potential modifying effects of macronutrients, amino acids, fatty acids, micronutrients, and dietary bioactive compounds. The review further considers how exercise and nutritional context may influence features of immunosenescence and inflammaging and examines their potential relevance to vaccine responses and infection-related host defense. Importantly, changes in circulating biomarkers or immune-cell phenotypes are not assumed to represent improved immune competence or clinical protection. Instead, the available evidence is interpreted according to exercise modality and dose, training status, age, sex, nutritional and metabolic context, and the level of biological evidence. Overall, this framework highlights the potential for exercise-nutrition interactions to shape immune-metabolic communication while emphasizing that several proposed myokine-mitochondrial-immune links remain associative or mechanistic hypotheses requiring prospective human investigation.
    Keywords:  exercise; host defense; immune aging; immunometabolism; mitochondrial adaptation; myokines; nutrition
    DOI:  https://doi.org/10.3389/fimmu.2026.1987314
  21. PLoS Pathog. 2026 Nov;22(11): e1014789
      The glycolysis is crucial for the material and energy source of virus infection. However, the role of post-transcriptional modification, particularly N6-methyladenosine (m6A), in regulating virus-induced glycolysis in invertebrate remains unclear. Here, we demonstrate that METTL3-mediated m6A modification of lactate dehydrogenase (LDH) mRNA increased in shrimp upon white spot syndrome virus (WSSV) infection to promote glycolysis. An m6A site in the LDH mRNA is recognized by the m6A reader YTH domain family protein 3 (YTHDF3), which recruits translation initiation factor core subunit eIF4A to enhance LDH translation elongation and mRNA stability. LDH-derived lactate acts as a key metabolite responsible for lactylation of histone lysine residues that stimulates methyltransferase-like 3 (mettl3) gene transcription from chromatin directly. High levels of METTL3 were responsible for the upregulation of LDH, thereby facilitating lactate production by glycolysis. In summary, our results demonstrate that m6A and lactate function as viral responders, revealing a mechanistic link between RNA epitranscriptomic regulation and metabolic reprogramming, and establishes an indispensable role of histone lactylation, which performs to connect innate immunity and metabolism in the condition of virus infection.
    DOI:  https://doi.org/10.1371/journal.ppat.1014789
  22. Mol Cells. 2026 Nov 20. pii: S1016-8478(26)00108-1. [Epub ahead of print] 100417
      Immune cells continuously adapt to local tissue environments, and this functional plasticity plays a critical role in tissue homeostasis and metabolic disease. Emerging evidence indicates that histone post-translational modifications (HPTMs) contribute to immune cell adaptation by linking metabolic and environmental signals to transcriptional regulation. Beyond canonical histone acetylation and methylation, recently characterized modifications, including lactylation, crotonylation, and β-hydroxybutyrylation, have expanded our understanding of metabolism-dependent chromatin regulation. Advances in epigenomic technologies have further accelerated the characterization of these dynamic regulatory mechanisms. In this review, we summarize the molecular mechanisms through which metabolic pathways and metabolites regulate HPTMs and shape immune cell function. We further highlight emerging evidence of histone remodeling in immune cells during systemic metabolic dysfunction and within adipose and hepatic microenvironments, with particular emphasis on obesity and metabolic dysfunction-associated steatotic liver disease. Finally, we address current knowledge gaps and future directions for understanding metabolic-epigenetic interactions within tissue niches. Collectively, this review provides an integrated perspective on how metabolism-driven histone remodeling shapes immune cell plasticity and contributes to metabolic disease, providing insights into potential therapeutic targets.
    Keywords:  Histone modification; Immunometabolism; Metabolic disease; Metabolite signaling; Tissue-resident immune cells
    DOI:  https://doi.org/10.1016/j.mocell.2026.100417
  23. bioRxiv. 2026 Nov 09. pii: 2026.11.03.764124. [Epub ahead of print]
       Background: Macrophages must coordinate immune activation with maintenance of cellular cholesterol homeostasis, yet the transcriptional mechanisms integrating these processes remain incompletely understood. Activating transcription factor 3 (ATF3) suppresses inflammatory and interferon responses and has been implicated in macrophage lipid metabolism, suggesting a role in coordinating immune and sterol-responsive transcriptional programs.
    Methods: Wild-type and ATF3-deficient bone marrow-derived macrophages were analyzed by bulk RNA sequencing following Toll-like receptor stimulation and under conditions of sterol loading or depletion. Cholesterol content, cytokine production, and sterol-responsive gene expression were quantified. Human metabolic dysfunction-associated steatotic liver disease (MASLD) datasets and Kupffer cell-specific ATF3 knockout mice were used to assess disease relevance in vivo.
    Results: ATF3 deficiency enhanced inflammatory and interferon-responsive transcriptional programs while suppressing a sterol-responsive gene module enriched for SREBP2 target genes. This phenotype was conserved across diverse Toll-like receptor stimuli and accompanied by persistent Ch25h upregulation. Despite exhibiting elevated cellular cholesterol, ATF3-deficient macrophages retained transcriptional responsiveness to sterol loading and depletion while demonstrating reduced induction of SREBP2-dependent genes across conditions. IFNAR blockade reduced interferon-responsive gene expression but did not normalize Ch25h or sterol-responsive gene expression. In contrast, CRISPR-mediated reduction of Ch25h partially restored sterol-responsive gene expression in inflammatory ATF3-deficient macrophages. In human MASLD, hepatic ATF3 expression positively correlated with disease severity. In mice, ATF3 was preferentially induced in Kupffer cells during metabolic stress, and Kupffer cell-specific deletion of ATF3 increased liver injury and Kupffer cell lipid accumulation.
    Conclusions: ATF3 supports sterol-responsive transcriptional programs while restraining inflammatory activation in macrophages. ATF3 loss results in elevated cellular cholesterol, impaired SREBP2-dependent gene expression, and persistent derepression of Ch25h , which contributes to but does not fully explain the sterol phenotype. These findings identify ATF3 as a coordinator of macrophage adaptation to inflammatory and metabolic stress and support a protective role for Kupffer cell ATF3 during metabolic liver disease.
    DOI:  https://doi.org/10.64898/2026.11.03.764124
  24. New Phytol. 2026 Nov 15.
      Diatoms are a widespread group of phytoplankton that disproportionately influence the global carbon cycle through substantial contributions to primary production and carbon export in the ocean. Marine viruses are major drivers of host metabolic reprogramming and mortality, and it is increasingly clear that RNA viruses, which primarily infect eukaryotes, are abundant and distributed throughout the global ocean. Using an integrated, multi-omics approach, we characterized the molecular and metabolic response of the model, bloom-forming, centric diatom Chaetoceros tenuissimus to RNA virus infection. Time-resolved transcriptomics revealed coordinated, differential expression of more than a third of host genes before host lysis, eliciting a cascade of metabolic responses that included early shifts in sulfur and lipid metabolism, induction of nitrogen assimilation pathways and late-stage activation of stress, signaling and death-related genes. Lipidomics revealed substantial cellular enrichment of phosphatidylethanolamine, ceramide, and triacylglycerol during RNA virus infection, as well as an infection-specific shift in fatty acid composition. Collectively, these findings provide insight into the intracellular requirements for RNA virus replication and illustrate a fundamental shift in resource partitioning in infected diatoms, advancing our understanding of how RNA virus infection transforms diatom host metabolic function and downstream ecosystem dynamics.
    Keywords:  diatom; host metabolic reprogramming; lipidomics; marine RNA viruses; phytoplankton host–virus interactions; transcriptomics
    DOI:  https://doi.org/10.1111/nph.71757
  25. Blood. 2026 Nov 18. pii: blood.2026035669. [Epub ahead of print]
      Chimeric antigen receptor (CAR) T-cell therapy can cause immune effector cell-associated neurotoxicity syndrome (ICANS), in which blood-brain barrier (BBB) disruption is a central pathological feature, yet the underlying mechanisms remain poorly understood. Here, we identify indoleamine 2,3-dioxygenase 1 (IDO1)-dependent metabolic reprogramming in cerebrovascular endothelial cells as a mediator linking CAR-T-associated inflammation to BBB dysfunction and neurotoxicity. Patients who developed ICANS exhibited elevated plasma IDO1 activity, a metabolic phenotype recapitulated in a syngeneic CAR-T mouse model characterized by BBB leakage, hippocampal neuronal and synaptic injury, and neurobehavioral impairment. In brain endothelial cells, IDO1 promoted endothelial activation, junctional protein loss, and barrier dysfunction. Pharmacological inhibition and endothelial-specific IDO1 silencing restored barrier integrity and improved neurological outcomes. Mechanistically, IDO1 activation redirected endothelial kynurenine metabolism toward kynureninase (KYNU)-driven anthranilic acid (AA) production, thereby disrupting Wnt/β-catenin-dependent tight junction maintenance. These findings establish the endothelial IDO1-KYNU-AA-Wnt/β-catenin axis as a pathogenic pathway in ICANS and identify endothelial IDO1-dependent metabolism as a potential therapeutic target for preserving BBB integrity and mitigating CAR-T-associated neurotoxicity.
    DOI:  https://doi.org/10.1182/blood.2026035669
  26. Inflamm Bowel Dis. 2026 Nov 17. pii: izag237. [Epub ahead of print]
      Inflammatory bowel disease is a chronic inflammatory disease characterized by mucosal immunity dysregulation, epithelial barrier dysfunction, and gut microbiome dysbiosis. While cytokine-targeted therapies have improved clinical outcomes, many patients remain refractory or relapse, emphasizing the need for additional therapeutic approaches. Recent evidence suggests that mitochondrial metabolism in the intestinal epithelium regulates mucosal homeostasis, immune cell recruitment, and susceptibility to inflammation. However, it remains controversial whether mitochondrial dysfunction is a cause or a consequence of intestinal inflammation. Epithelial energetic deficiency and barrier dysfunction are associated with impaired oxidative phosphorylation, defective short-chain fatty acid utilization, redox imbalance, and faulty mitochondrial quality control. Indeed, impaired mitophagy promotes mitochondrial DNA (mtDNA) release through voltage-dependent anion channel 1 (VDAC1) oligomerization and mitochondrial permeability transition pore opening. Extracellular mtDNA acts as a damage-associated molecular pattern, activating cyclic GMP-AMP synthase-stimulator of interferon genes, toll-like receptor 9, and NLR family pyrin domain-containing 3 inflammasome pathways that amplify mucosal inflammation. These metabolic changes alter luminal oxygen and microbiome composition, whereas microbial metabolites, particularly tryptophan-derived indoles and kynurenines, modulate epithelial mitochondrial function through aryl hydrocarbon receptor signaling. These findings support a bidirectional microbiome-mitochondria-immune axis that potentiates intestinal inflammation. In this review, we summarize the current evidence of how epithelial mitochondrial dysfunction associates with intestinal inflammation. We discuss how mitochondrial metabolism interfaces with microbial ecology and immune regulation to shape disease pathogenesis. We also discuss therapeutic strategies targeting this axis: mitochondrial-targeted antioxidants (eg, MitoQ), VDAC1 inhibitors, bile-acid derivatives (eg, tauroursodeoxycholic acid), and metabolite-based therapies to restore microbial tryptophan metabolism. These approaches target mitochondrial bioenergetics and microbial metabolic cross-talk with the potential to restore microbiome-immune homeostasis, preserve barrier integrity, and complement conventional immune-directed therapies.
    Keywords:  epithelial bioenergetics; immunometabolism; inflammatory bowel disease; microbiome-mitochondria-immune axis; mitochondrial quality control; tryptophan metabolism
    DOI:  https://doi.org/10.1093/ibd/izag237
  27. Sci China Life Sci. 2026 Nov 09.
      Chronic metabolic diseases, such as type 2 diabetes, non-alcoholic fatty liver disease (NAFLD) and atherosclerosis, constitute a major burden on global health. The pathogenesis of these diseases is closely related to immune-metabolic disorders. Immunometabolism refers to the changes in intracellular metabolic pathways within immune cells that alter their functions. The lipid metabolism of macrophages is an important aspect of immunometabolism. Macrophages play a crucial role in tissue homeostasis and inflammatory responses through their plasticity. Aging macrophages show distinct lipid metabolic characteristics in comparison with young cells, which may be associated with the progression of chronic metabolic diseases. This article aims to explore how normal and aging macrophages affect the occurrence and development of chronic metabolic diseases.
    Keywords:  aging; chronic metabolic diseases; lipid metabolism; macrophages
    DOI:  https://doi.org/10.1007/s11427-026-3490-5
  28. Expert Rev Clin Immunol. 2026 Nov 20.
      
    Keywords:  Endogenous immune stimuli; epigenetics; extracellular matrix; innate immune memory; macrophages; metabolism; monocytes; rheumatoid arthritis flare; tolerance; trained immunity
    DOI:  https://doi.org/10.1080/1744666X.2026.2768407
  29. bioRxiv. 2025 Nov 03. pii: 2025.11.01.686055. [Epub ahead of print]
      The tumor microenvironment (TME) programs cancer cells to influence therapeutic responses. Macrophages residing in TME switch from pro-phagocytic to tumor-promoting and immunosuppressive phenotypes as cancer develops. While these pro-tumor functions of macrophages are associated with poor outcomes, the underlying mechanisms by which bone-marrow (BM)-associated macrophages fuel myeloid malignancy and their precise contribution to relapse remain undissected. Here, we show expansion of monocyte/macrophage population in leukemia patients post-chemotherapy relapse, and spatial proximity of macrophages to leukemia blasts in the BM niche. This proximity proved functionally consequential-depletion of macrophages delayed leukemia relapse post cytarabine (AraC), a frontline chemotherapy, in patient-derived xenografts (PDX) and syngeneic leukemia models. Mechanistically, a pyrimidine metabolite, deoxycytidine (dC), secreted by BM macrophages, is taken up by leukemia cells to directly inhibit deoxycytidine kinase (DCK) to hamper AraC activation and subsequent resistance in a cell non-autonomous manner. Diagnosis AML patients exhibited significantly higher circulating dC levels than healthy donors, and dC levels further increased following chemotherapy. SAMHD1, which catalyzes deoxynucleoside triphosphates (dNTPs) into deoxynucleoside, was highly abundant in macrophages and mediated dC accumulation. Blockade of dC production in mouse and human macrophages via genetic and pharmacological inhibition of SAMHD1 or DHODH , a critical enzyme in pyrimidine synthesis, restored AraC sensitivity. Combination with DHODH inhibitors significantly delayed AraC relapse in human PDX and mouse syngeneic AML models. Collectively, we identify a metabolic immune-leukemia crosstalk in which SAMHD1 high macrophages mediates chemoresistance by secreting pyrimidine metabolites and propose macrophage metabolic reprogramming as a tractable strategy to overcome TME-driven chemoresistance in myeloid leukemia.
    DOI:  https://doi.org/10.1101/2025.11.01.686055
  30. Pharmacol Res. 2026 Nov 15. pii: S1043-6618(26)01659-2. [Epub ahead of print] 109744
      Hepatocellular carcinoma (HCC) arises in chronically injured, often fibrotic or cirrhotic liver, where metabolism, immunity, vascular and stromal organization, disease etiology, tumor state, and hepatic reserve are tightly interconnected. Although immune checkpoint inhibitor (ICI)-based therapies have expanded treatment options for advanced HCC, responses remain heterogeneous because of both primary and acquired resistance. Metabolic reprogramming may shape these outcomes by altering nutrient availability, metabolite accumulation, antigen presentation, immune-cell fitness, stromal organization, and spatial immune access. This review provides an evidence-weighted assessment of major immunometabolic mechanisms in HCC, focusing on the glycolysis-hypoxia-lactate and tryptophan-kynurenine/IDO1 axes, lipid and cholesterol metabolism, purinergic signaling, mitochondrial and redox regulation, and ferroptosis. We emphasize that these pathways are context dependent, with effects determined by cellular source, differentiation state, spatial organization, and tumor-intrinsic versus immune-cell metabolic adaptation. Molecular heterogeneity, etiology, and cirrhosis are considered together, with WNT-β-catenin/CTNNB1-associated states illustrating their intersection with immune organization and ICI response. Because translational maturity varies widely, we distinguish mechanistic evidence, biomarker association, predictive validation, and clinical utility. We propose a framework integrating HCC specificity, primary human validation, cellular and spatial localization, causal immune-functional evidence, treatment-linked and longitudinal assessment, biomarker feasibility, and liver-specific safety. The framework also considers intervention timing and the distinction between primary and acquired ICI resistance. It may guide progression from metabolic discovery to spatially resolved mechanism, biomarker development, pharmacodynamic validation, and clinical evaluation while accounting for cirrhosis-associated remodeling, hepatic reserve, and treatment-related toxicity.
    Keywords:  Hepatocellular carcinoma; Immune dysfunction; Immunometabolism; Immunotherapy resistance; Metabolic reprogramming; Translational biomarkers
    DOI:  https://doi.org/10.1016/j.phrs.2026.109744
  31. Proc Natl Acad Sci U S A. 2026 Nov 24. 123(47): e2606185123
      Short-chain fatty acids (SCFAs) produced by gut microbiota are key modulators of intestinal homeostasis and immune responses. Although their anti-inflammatory roles are well established, the mechanisms by which SCFAs-FFAR2 shapes neutrophil function and influences intestinal inflammation remain unclear. Here, we demonstrate that dietary fiber or acetate protect mice from DSS-induced colitis despite increasing neutrophil infiltration into the intestinal tissue. Importantly, neutrophils are required for the protective effects of acetate, which are also dependent on FFAR2 signaling and IL-22. Neutrophil-specific deletion of FFAR2 impairs IL-22 responses, increases epithelial damage, and exacerbates colitis, while administration of recombinant IL-22 is sufficient to restore acetate protection in this context. Analysis of human ulcerative colitis biopsies reveals increased FFAR2+ neutrophils correlating with IL-22-related gene signatures. These findings indicate that acetate-FFAR2-neutrophil-IL-22 axis modulates intestinal inflammation, revealing a metabolic mechanism that links microbiota-derived signals to mucosal protection and highlighting potential therapeutic targets for inflammatory bowel diseases.
    Keywords:  FFAR2; IL-22; microbiota; neutrophil; short-chain fatty acids
    DOI:  https://doi.org/10.1073/pnas.2606185123
  32. Immunology. 2026 Nov 15.
      Hepatocellular carcinoma (HCC) undergoes profound metabolic reprogramming, yet the specific lipid species responsible for driving immunosuppressive remodelling remain unclear. BODIPY 493/503 and Oil Red O staining were used to assess the lipid accumulation in macrophages treated with tumour-conditioned medium. Immunofluorescence analysis was performed to visualize lipid droplets, while qPCR and flow cytometry were conducted to evaluate the expression of CD36, CD163, CD206 and PD-L1 on macrophages. Transmission electron microscopy assay was applied to observe mitochondrial morphology and fission. Fatty acid screening was performed to identify the CD36-mediated signalling pathway. In vivo validation was performed using a DEN/CCl4-induced HCC mouse model treated with oleic acid alone or in combination with the CD36 inhibitor SSO. We demonstrate that lipid-rich conditioned medium from HCC cells (HCC-CM) promotes CD36-associated intracellular lipid accumulation in tumour-associated macrophages (TAMs). This lipid accumulation drives M2 polarization, mitochondrial fission and upregulation of PD-L1 expression in TAMs and is associated with impaired CD8+ T-cell effector function. Among six representative fatty acids screened, oleic acid emerged as the strongest candidate and recapitulated these effects through CD36-dependent lipid uptake, mitochondrial remodelling and PD-L1 upregulation. SSO co-treatment attenuated these effects both in vitro and in a DEN/CCl4-induced primary liver cancer model, where it was associated with improved CD8+ T-cell effector function and reduced tumour growth. Our findings identify oleic acid as a key lipid mediator in TAM reprogramming and highlight CD36 as a potential therapeutic target to restore antitumour immunity in HCC.
    Keywords:  CD36; CD8+ T cell; HCC; lipid; macrophages
    DOI:  https://doi.org/10.1111/imm.70233
  33. Geroscience. 2026 Nov 17.
      Older adults experience disproportionate morbidity and mortality from Clostridioides difficile infection (CDI); however, existing toxoid- and receptor binding domain (RBD)-based vaccines elicit suboptimal protection in aged hosts due to the age-associated defects in CD4+ T cell function, T follicular helper (TFH) cell activation, and antibody quality. We evaluated whether adenosine deaminase (ADA), an enzymatic immune modulator that degrades immunosuppressive adenosine, and improves GC TFH differentiation and survival, could reverse these age-related impairments when co-delivered with DNA vaccine plasmids targeting toxin A and B RBDs (pRBD). In aged mice, pRBD vaccination alone produced markedly reduced toxin-specific effector/memory CD4+ T cells, diminished TFH activation, and poor toxin A neutralization compared to vaccinated young mice. Co-immunization with plasmid-encoded adenosine deaminase-1 (pADA) restored toxin-specific CD4+ T cell generation and cytokine production, activation-induced marker (AIM) TFH responses, and antibody-mediate toxin neutralization to levels comparable to young adults. Mechanistically, pADA co-immunization was associated with the reduction of CXCR4 on germinal center (GC) TFH cells-a phenotype previously linked to impaired GC positioning and diminished B cell help in aging-suggesting that ADA may improve humoral quality through modulation of CXCR4 expression, a pathway previously associated with GC TFH positioning. These immune enhancements corresponded with improved clinical outcomes in morbidity, mortality, and weight loss following C. difficile spore challenge of aged mice. Finally, pADA significantly reduced adenosine levels in aged lymph nodes, implicating a potential enzymatic-based regulation of GC immunosenescence. Together, these findings identify ADA as a metabolic adjuvant capable of reversing key features of vaccine immunosenescence and highlight adenosine-dependent CXCR4 regulation as a tractable axis for improving vaccine efficacy in older populations.
    Keywords:   Clostridioides difficile ; Adenosine Deaminase (ADA); Aging; Humoral immunity; Immunosenescence; T follicular helper (TFH) cell; Vaccine adjuvant
    DOI:  https://doi.org/10.1007/s11357-026-02605-0
  34. Res Sq. 2026 Nov 10. pii: rs.3.rs-10375256. [Epub ahead of print]
      Checkpoint-responsive exhausted CD8 + T cells sustain immunity during chronic infection and cancer, but the tissue-derived signals that preserve these cells remain poorly defined. Here, we identify extracellular ATP sensing through P2RX7 as a microenvironmental circuit that maintains progenitor exhausted (T PEX ) and tissue-resident exhausted (TR TEX ) CD8 + T cells. P2RX7 was enriched in T PEX and TR TEX cells and was required cell-intrinsically to preserve their abundance, diversity, and developmental competence during chronic viral infection. Loss of P2RX7 restricted early progenitor trajectories and induced mitochondrial dysfunction, lipid peroxidation, and terminal exhaustion-associated phenotypes. Mechanistically, P2RX7-dependent Ca 2+ influx activated NFAT/AP-1 signaling, which induced KLF3 to promote mitochondrial fitness, subset development, and persistence of T PEX and TR TEX cells. P2RX7 also supported CD8 + T cell expansion after PD-1 blockade, whereas pharmacologic P2RX7 activation enhanced antitumor immunity in preclinical models. These findings define an extracellular ATP-P2RX7-KLF3 program that couples tissue damage sensing to metabolic adaptation and persistence of checkpoint-responsive exhausted CD8 + T cells.
    DOI:  https://doi.org/10.21203/rs.3.rs-10375256/v1
  35. J Transl Med. 2026 Aug 24. pii: 1442. [Epub ahead of print]24(1):
       BACKGROUND: Chronic systemic stress (CSS) is associated with the progression of hepatocellular carcinoma (HCC), yet the molecular mechanisms linking physiological exhaustion into intratumoral immune evasion remain fundamentally opaque. We aimed to decode the biological axis bridging systemic allostatic load (AL), lactate metabolism, and localized immune collapse.
    METHODS: Leveraging the NHANES cohort, we established epidemiological links between AL, lactate, and mortality. An integrative consensus machine-learning framework derived a stress-lactylation signature (SLS). We mapped the SLS-associated microenvironment via single-cell/spatial transcriptomics, dissecting mechanistic interactions through in silico network perturbations and pharmacogenomics, which were subsequently corroborated by comprehensive ex vivo clinical tissue analyses and in vitro functional co-culture validations.
    RESULTS: High AL independently predicted elevated all-cause mortality in adults with liver dysfunction, correlating robustly with systemic lactate. Projecting this macro-level vulnerability into the tumor microenvironment, we distilled a 6-gene SLS as a potent HCC prognosticator. Multi-omics deconvolution revealed that high-SLS tumors compartmentalize into immunosuppressive niches where SPP1⁺ macrophages mediate the metabolic suppression of CD8⁺ T cells. Crucially, ex vivo analyses of HCC patient tissues verified elevated histone lactylation (H3K9la) and its profound spatial co-localization with active glycolysis (GLUT1⁺) and SPP1⁺ macrophages. Furthermore, in vitro co-culture models confirmed that blocking tumor-derived lactate directly attenuates M2-like polarization and downregulates SPP1 expression in recipient macrophages. Finally, Adavosertib was functionally validated as a precision dual-targeting agent, effectively inhibiting both upstream tumor lactate production and downstream macrophage-associated remodeling (CTSS).
    CONCLUSIONS: We delineate a comprehensive multi-scale blueprint linking CSS to localized immune failure. The SLS provides an accurate prognostic tool, while our experimental validations expose a lactate-driven macrophage metabolic trap, unveiling a precision dual-inhibition strategy to reinvigorate anti-tumor immunity in stress-burdened HCC.
    Keywords:  Allostatic load; Dual-targeted therapy; Hepatocellular carcinoma; Lactylation; Tumor-associated macrophages
    DOI:  https://doi.org/10.1186/s12967-026-08865-w
  36. Inflamm Res. 2026 Nov 20. pii: 258. [Epub ahead of print]75(1):
       AIM: To investigate the synergistic impact of hyperuricemia and systemic inflammation on clinical infection susceptibility and the mechanisms of pancreatic β-cell bioenergetic failure.
    METHOD: A retrospective clinical cohort analysis evaluated correlations between glycemic status, immuno-metabolic markers, and pathogen risks. Mechanistically, β-cells exposed to uric acid (UA) and cytokines were assessed for real-time bioenergetics, redox proteomics, and cell fate trajectories.
    RESULT: Clinical immuno-metabolic profiling demonstrated progressive elevation of serum uric acid, CRP, lipase, and triglycerides across glycemic stages. Functional experiments further demonstrated that uric acid lowered the threshold for inflammatory cytokine-induced mitochondrial dysfunction, impaired glucose-stimulated insulin secretion, and β-cell apoptosis. Pharmacological interruption of the uric acid-IL-1 inflammatory axis restored mitochondrial function and preserved β-cell viability.
    CONCLUSION: Hyperuricemia acts as a metabolic primer that sensitizes β-cells to cytokine-induced toxicity, precipitating irreversible mitochondrial collapse. Targeting this synergistic UA-inflammation axis offers a vital therapeutic strategy to preserve functional β-cell mass and mitigate type 2 diabetes-associated infectious complications.
    Keywords:  Cellular senescence; Diabetes-associated infection; Meta-inflammation; Mitochondrial bioenergetics; Mitochondrial oxidative stress; Pancreatic beta-cell failure
    DOI:  https://doi.org/10.1007/s00011-026-02396-2
  37. Rheum Dis Clin North Am. 2027 Feb;pii: S0889-857X(26)00064-5. [Epub ahead of print]53(1): 1-13
      While Sjögren's disease (SjD) is a chronic autoimmune disorder marked by lymphocytic infiltration of the salivary and lacrimal glands, profound fatigue represents one of the most significant unmet needs in this disease process. Increasingly, emerging evidence highlights burgeoning roles for immunometabolism not only in lymphocyte activation and differentiation but also in driving mitochondrial dysfunction that contributes to fatigue in related autoimmune conditions like lupus. We outline priority directions for future immunometabolism research efforts in SjD and discuss therapeutic opportunities afforded by emerging insights in the field.
    Keywords:  Free radicals; Metabolism; Metabolomics; Mitochondria; Sjögren’s disease
    DOI:  https://doi.org/10.1016/j.rdc.2026.09.001
  38. Nat Metab. 2026 Nov;8(11): 2356-2378
      White adipose tissue expandability protects against metabolic disease, yet the epigenetic programmes that maintain the macrophage states supporting this adaptation remain poorly defined. Here we show that the H3K27 demethylase KDM6B sustains LYVE1+ adipose tissue perivascular macrophages (PVMs) during diet-induced white adipose tissue expansion, thereby maintaining adipogenic balance. In humans, KDM6B expression in adipose tissue macrophages associates with insulin sensitivity, glycaemic control and reduced inflammation. In mice, myeloid Kdm6b deletion reprogrammes septal and capsular LYVE1+ macrophages towards a CLEC1A+ hypermetabolic perivascular state, leading to defective adipogenesis, adipocyte hypertrophy, vascular rarefaction, inflammation and impaired glucose homeostasis. Mechanistically, KDM6B limits H3K27me3 deposition at the Bmp2 locus to maintain macrophage-derived BMP2 signalling to adipose progenitors. Myeloid Bmp2 deletion partially recapitulates Kdm6b-deficient adipose dysfunction, whereas recombinant BMP2 promotes homeostatic tissue remodelling. Collectively, KDM6B acts as an epigenetic switch controlling the metabolic fate of LYVE1+ PVMs, maintaining the balance between adipogenesis-supportive and metabolic PVM states that determine adipose tissue expandability and metabolic homeostasis.
    DOI:  https://doi.org/10.1038/s42255-026-01639-0
  39. J Transl Med. 2026 Aug 24. pii: 1440. [Epub ahead of print]24(1):
      Tumor-associated macrophages (TAMs) play a pivotal role in tumor progression and immune evasion, with recent evidence indicating that metabolic reprogramming is crucial in determining their functional phenotype. Alterations in glucose, amino acid, and lipid metabolism are central to the regulation of TAMs plasticity, driving the shift between pro-inflammatory (M1) and anti-inflammatory (M2) states. M1 macrophages predominantly rely on glycolysis and aerobic metabolism to support their pro-inflammatory functions, while M2 macrophages exhibit enhanced oxidative phosphorylation, which facilitates tissue repair and immune suppression. Given these metabolic distinctions, targeting key metabolic pathways in TAMs presents a promising strategy for reprogramming the tumor microenvironment and enhancing anti-tumor immunity. This review examines the metabolic differences between these distinct macrophage populations, focusing on the regulation of glucose, amino acid, and lipid pathways. Furthermore, we evaluate emerging therapeutic strategies targeting these metabolic pathways aimed at reprogramming TAMs toward an anti-tumor phenotype, enhancing anti-tumor immunity, and overcoming therapeutic resistance. Finally, we discuss the translational progresses and challenges of metabolic interventions, highlighting the potential of targeting macrophage metabolism to convert refractory tumors into immunologically responsive ones and improve the clinical outcomes of cancer immunotherapy.
    DOI:  https://doi.org/10.1186/s12967-026-08845-0
  40. J Exp Med. 2026 Dec 07. pii: e20260044. [Epub ahead of print]223(12):
      Mycobacterium tuberculosis (Mtb) persists within the host despite robust immune responses and prolonged multidrug therapy, underscoring the need to better understand the mechanisms that drive persistence and treatment failure. Emerging evidence indicates that redox metabolism is a central interface governing host-pathogen interactions during tuberculosis (TB). This review discusses how redox cross talk integrates immune signaling with bacterial physiology through interconnected pathways involving iron metabolism, lipid peroxidation, mitochondrial bioenergetics, central carbon metabolism, and antioxidant defenses. We highlight how these processes generate physiological, metabolic, and spatial heterogeneity within infected macrophages and granulomas, promoting bacterial persistence, drug tolerance, and tissue pathology. Finally, we discuss therapeutic strategies targeting redox-dependent vulnerabilities in both the host and the pathogen, including modulation of macrophage bioenergetics, nuclear factor erythroid 2-related factor 2 (NRF2) signaling, ferroptosis, and mycobacterial respiration. Integrating host and bacterial redox biology provides a unified framework for developing host-directed and pathogen-directed interventions to improve TB treatment and limit long-term disease sequelae.
    DOI:  https://doi.org/10.1084/jem.20260044
  41. Front Nutr. 2026 ;13 1833495
      Short-chain fatty acids (SCFAs) are key gut-derived metabolites, mainly including acetate, propionate, and butyrate, which directly and indirectly interact with or influence immunity. SCFAs regulate renal and systemic immune responses via G protein-coupled receptor (GPR) signaling, inhibition of histone deacetylase (HDAC) activity, and energy metabolism. SCFAs affect not only infiltrated immune cells but also renal resident cells, leading to changes in the renal inflammatory microenvironment. In this review, we summarize the role of SCFAs in systemic and renal immune regulation, by which they may affect the pathogenesis and progression of kidney diseases. Furthermore, we discuss the feasibility of SCFA-targeted intervention as a promising therapeutic strategy for kidney diseases and the challenges faced in clinical application.
    Keywords:  gut-kidney axis; immunity; inflammation; kidney disease; short-chain fatty acids
    DOI:  https://doi.org/10.3389/fnut.2026.1833495
  42. Inflamm Regen. 2026 Sep 09. pii: 44. [Epub ahead of print]46(1):
       BACKGROUND: Periodontal ligament stem cells (PDLSCs) possess potent immunomodulatory and regenerative properties, positioning them as a promising therapeutic strategy for oral inflammatory diseases. However, the metabolic mechanisms governing PDLSC-immune cell crosstalk, particularly in the context of macrophage-driven inflammation, remain incompletely understood.
    METHODS: A Transwell coculture model of PDLSCs and THP-1-derived macrophages was established to investigate PDLSC-mediated regulation of macrophage inflammasome activation and inflammation. Transcriptomic, proteomic, and metabolomic profiling with integrated pathway analysis identified metabolic pathways associated with PDLSC-mediated immunomodulation. Triacetyluridine (TAU) was subsequently investigated as a pyrimidine metabolism-related modulator using network pharmacology, functional enrichment, and molecular docking analyses. Its anti-inflammatory effects were evaluated in macrophages, and tissue-reparative effects were assessed in a murine oral ulcer model.
    RESULTS: PDLSC coculture markedly suppressed activation of the NLRP3 inflammasome and its downstream mediators, including caspase-1, IL-1β, and IL-18, at both transcriptional and protein levels. In the murine oral ulcer model, PDLSC treatment preserved epithelial architecture, reduced immune cell infiltration, and enhanced expression of regenerative markers. Integrated multiomics analyses identified pyrimidine metabolism as a prominent metabolic pathway altered in macrophages cocultured with PDLSCs, characterized by coordinated changes in pyrimidine metabolites and metabolism-associated proteins. TAU-associated analyses identified pyrimidine metabolism as a principal pathway, with UPP1, TYMP, and DPYD as representative targets, and docking predicted potential interactions of TAU with these enzymes. TAU treatment reproduced several anti-inflammatory and tissue-reparative features associated with PDLSC treatment, suppressing inflammasome-related gene expression in vitro and promoting mucosal healing in vivo.
    CONCLUSIONS: PDLSCs modulate macrophage inflammation in association with coordinated remodeling of Pyrimidine metabolism. Functional studies with TAU further support a role for pyrimidine metabolic regulation in controlling inflammatory responses and tissue repair, highlighting this metabolic pathway as a potential therapeutic target for oral inflammatory diseases.
    Keywords:  Immunometabolism; Inflammasome; Oral inflammation; Periodontal ligament stem cells; Pyrimidine metabolism; Triacetyluridine
    DOI:  https://doi.org/10.1186/s41232-026-00443-3
  43. bioRxiv. 2026 Nov 06. pii: 2026.11.04.764347. [Epub ahead of print]
      Pathogen infection profoundly remodels host metabolism. Whether hosts sense specific pathogen-induced metabolic changes to identify microbial infection is not known. Here, we find that depletion the monounsaturated fatty acid oleate is a metabolic pattern of pathogenesis, specifically surveilled by the nematode C. elegans to identify active infection with a bacterial pathogen. We previously demonstrated that the enzymatic TIR (Toll/interleukin-1 receptor/resistance)-domain containing protein, TIR-1/SARM1 - the key upstream activator of p38 MAPK PMK-1 immunity - is a guard protein in an effector-triggered immune response, positioned specifically on the surface of lysosome-related organelles to sense the toxic effects of bacterial infection. Here, we show that acute loss of oleate in intestinal cells during bacterial infection causes lysosome-related organelles to collapse, which induces the aggregation and activation of TIR-1/SARM1. Further, we find that oleate deficiency is a host vulnerability that concomitantly activates the c-Jun N-terminal kinase (JNK) KGB-1 nutrient sensing pathway - an adaptive response that promotes expression of TIR-1/SARM1 on lysosome-related organelles and is required for survival during infection. These data establish a mechanistic connection between fatty acid nutrition and innate immune regulation, and reveal that specific changes in host metabolism are surveilled to identify pathogen attack.
    DOI:  https://doi.org/10.64898/2026.11.04.764347
  44. FASEB J. 2026 Nov 30. pii: e72462. [Epub ahead of print]40(22):
      Sleep deprivation (SD) disrupts neuroimmune and metabolic homeostasis, but whether circulating factors generated after sleep loss alter microglial responses to purinergic pharmacological modulation remains unclear. P2Y12 is a microglia-enriched purinergic receptor that regulates process dynamics, calcium signaling, and microglial interactions with neurons and vascular-glial interfaces. Here, we established an in vitro serum-transfer model to test whether serum from sleep-deprived mice alters mitochondrial and Rhod-2 fluorescence responses to P2Y12-targeted compounds in BV2 cells. Mice were subjected to forced-wheel SD consisting of one wheel revolution every 2 s for 4 h per day over 4 consecutive days, and serum was obtained by cardiac blood collection followed by centrifugation. BV2 cells were treated with control or SD serum in the absence or presence of the P2Y12 antagonist MRS2395 or the P2Y12 agonist 2-MeSADP. Mitochondrial membrane potential was assessed by JC-1 red/green ratio imaging, mitochondrial network integrity by MitoTracker-based segmentation and skeletonization, and Rhod-2 fluorescence responses by single-cell F/F0 imaging. SD serum decreased the JC-1 ratio, increased maximal depolarization, reduced mitochondrial skeleton length and mitochondrial area fraction, and suppressed Rhod-2 responses. Under control-serum conditions, MRS2395 markedly enhanced Rhod-2 responses, whereas the increase in the area under the Rhod-2 response curve with 2-MeSADP was not significant after Holm correction. Under SD-serum conditions, however, neither compound consistently restored the mitochondrial or Rhod-2 response profile. Together, these findings link SD-serum exposure to mitochondrial impairment and attenuated Rhod-2 fluorescence responses in BV2 cells, and suggest that serum context may influence cellular responses to P2Y12-targeted compounds.
    Keywords:  BV2; JC‐1; MRS2395; P2Y12; calcium signaling; microglia; mitochondria; purinergic responsiveness; serum transfer; sleep deprivation
    DOI:  https://doi.org/10.1096/fj.202603419R
  45. Probiotics Antimicrob Proteins. 2026 Nov 19.
      Synbiotics have emerged as a potential intervention to alleviate high-fat diet (HFD)-induced metabolic and cardiovascular dysfunction. Here, we evaluated a novel synbiotic formulation in HFD-fed ApoE⁻/⁻ mice for its effects on lipid metabolism, intestinal and systemic T-cell immunity, and gut microbiome composition. ApoE⁻/⁻ mice were fed a HFD and treated with either vehicle or synbiotics for 4 weeks. Serum LDL cholesterol levels and hepatic lipid accumulation and cholesterol content were assessed. Expression of cholesterol metabolism genes was analyzed in the liver and in the small intestine. Flow cytometry was used to examine T-cell populations in mesenteric lymph nodes and spleen. Gut microbiome composition was profiled by shotgun sequencing, and short-chain fatty acid (SCFA) levels were quantified in serum and stool as well as aortic inflammation was evaluated. Synbiotic treatment significantly reduced LDL cholesterol and hepatic lipid accumulation without altering body or organ weights. In the intestine, synbiotics attenuated HFD-induced dysregulation of cholesterol metabolism genes and maintained hepatic cholesterol levels comparable to standard chow-fed mice. Immunologically, synbiotic-fed mice showed reduced Th17 cells in mesenteric lymph nodes and increased cytotoxic T cells in the spleen, indicating immune reprogramming. Despite HFD-induced dysbiosis, synbiotic treatment preserved SCFA-producing taxa, including Lactobacillus johnsonii, Bacteroides fragilis, and Eubacterium spp., and significantly increased fecal butyrate levels. Notably, synbiotic-treated mice showed a complete absence of aortic inflammation, in contrast to vehicle-treated HFD controls. In conclusion, synbiotic intervention ameliorates diet-induced cardiometabolic dysfunction in HFD-fed ApoE⁻/⁻ mice by modulating intestinal cholesterol metabolism, restoring microbiota-derived metabolite production, and reshaping T-cell responses. These findings support synbiotics as a promising strategy to counter diet-driven cardiometabolic dysfunction.
    Keywords:  Cholesterol Metabolism; Gut Microbiome; High-Fat Diet; Hypercholesterolemia; Synbiotics; T cells
    DOI:  https://doi.org/10.1007/s12602-026-11313-2
  46. iScience. 2026 Nov 20. 29(11): 118146
      Using high-resolution quantitative mass spectrometry, we explored how immune activation and the metabolic regulator mTORC1 shape the B cell proteome. Activation through the B cell receptor, CD40, and the IL-4 receptor caused extensive remodeling of the protein landscape, including increased expression of metabolic machinery and nutrient transporters needed to support growth and biosynthesis. Comparing T cell-dependent and T cell-independent stimulation identified both shared and distinct pathways driving these changes. Inhibition of mTORC1 revealed an essential role in activation-induced B cell growth, amino acid transporter expression, and protein production. mTORC1 also regulated expression of the transcription factor MYC and the transferrin receptor CD71. Inhibiting MYC largely mirrored the effects of mTORC1 inhibition, while reduced iron availability impaired B cell growth and protein synthesis. These findings provide a comprehensive map of B cell proteome remodeling and reveal key roles for mTORC1, MYC and iron in supporting activation-induced growth and protein production.
    Keywords:  B lymphocytes; MYC; iron; mTORC1
    DOI:  https://doi.org/10.1016/j.isci.2026.118146